Amy A. Sullivan's Insider Trades & SAST Disclosures
Amy A. Sullivan's most recent trade in Kirkland`s Inc was a trade of 3,839 Common Stock done at an average price of $1.2 . Disclosure was reported to the exchange on April 6, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Amy A. Sullivan.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.19 per share. | 06 Apr 2025 | 3,839 | 369,604 (2%) | 0% | 1.2 | 4,568 | Common Stock |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Apr 2025 | 215,000 | 215,000 | - | - | Stock Option (Right to Buy) | |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 233,333 | 373,443 (2%) | 1% | 0 | Common Stock | |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 27 Mar 2025 | 4,398 | 140,110 (1%) | 0% | 1.4 | 6,025 | Common Stock |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 23 Mar 2025 | 988 | 144,508 (1%) | 0% | 1.4 | 1,354 | Common Stock |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.83 per share. | 23 Dec 2024 | 10,250 | 84,632 | - | 0.8 | 8,483 | Common Stock |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.27 per share. | 06 Apr 2024 | 3,890 | 145,496 (1%) | 0% | 2.3 | 8,830 | Common Stock |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 60,000 | 60,000 | - | - | Stock Option | |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2024 | 44,492 | 149,386 (1%) | 0% | 0 | Common Stock | |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.54 per share. | 23 Mar 2024 | 988 | 105,439 (0%) | 0% | 2.5 | 2,510 | Common Stock |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.54 per share. | 23 Mar 2024 | 545 | 104,894 (0%) | 0% | 2.5 | 1,384 | Common Stock |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2024 | 280,000 | 280,000 | - | - | Stock Option (Right to Buy) | |
| Kirkland`s Inc | Amy A. Sullivan | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2024 | 50,000 | 106,427 (0%) | 0% | 0 | Common Stcok | |
| Kirkland`s Inc | Amy Sullivan A. | Director, President, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2024 | 50,000 | 50,000 | - | - | Stock Option | |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2023 | 49,382 | 49,382 | - | - | Warrants (Right to Buy) | |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 1.90 per share. | 09 Aug 2023 | 49,382 | 74,382 | - | 1.9 | 93,826 | Common Stock |
| Kirkland`s Inc | Amy A. Sullivan | President, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 54,653 | 54,653 | - | - | Stock Option | |
| Kirkland`s Inc | Amy A. Sullivan | President, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Apr 2023 | 39,894 | 53,580 (0%) | 0% | 0 | Common Stock | |
| Kirkland`s Inc | Amy A. Sullivan | SVP, CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 23 Mar 2023 | 988 | 14,751 (0%) | 0% | 2.7 | 2,648 | Common Stock |
| Kirkland`s Inc | Amy A. Sullivan | SVP, CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.67 per share. | 23 Mar 2023 | 545 | 14,206 (0%) | 0% | 2.7 | 1,455 | Common Stock |
| Kirkland`s Inc | Amy A. Sullivan | SVP, CMO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.67 per share. | 23 Mar 2023 | 520 | 13,686 (0%) | 0% | 2.7 | 1,388 | Common Stock |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Mar 2023 | 55,000 | 55,000 | - | - | Stock Option (Right to Buy) | |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.32 per share. | 17 Mar 2023 | 25,000 | 25,000 | - | 2.3 | 58,018 | Common Stock |
| IO Biotech Inc | Amy Sullivan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Oct 2022 | 288,152 | 288,152 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges